RF Stock Analysis: Eurazeo | PA
Asset Management | PA, France | Market Cap: 3.294m EUR | 12M Return: -6% | FR0000121121 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.25M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Eurazeo SE is a French-listed private equity and venture capital firm operating across multiple investment strategies, including growth capital, leveraged buyouts, buy-ins, and minority investments in listed public companies. It targets medium-sized and large companies, SMEs, and high-growth businesses, with no strict sector restrictions but a clear preference for areas such as smart cities, fintech, real estate, luxury, consumer brands, healthcare, digital health, and tech. The firm focuses on companies with differentiated concepts and global growth potential, particularly those benefiting from digital transformation and shifting consumer behaviors (e.g., mobility, online commerce, and new collaboration models).
Geographically, Eurazeo invests primarily in the United States and Western Europe, with a notable presence in New York, Paris, Italy, North America, and other European countries, and some exposure to China. According to the provided description, it typically invests between €50 million and €250 million in small-mid buyout transactions, €25 million to €100 million in growth-stage deals, and lower ticket sizes in earlier-stage ventures. The firm also engages in real estate activities, including the restructuring of large properties and residential, commercial, and office development projects in Western Europe.
As a publicly listed investment company in the asset management sub-industry, Eurazeo raises capital from public markets and limited partners to deploy across its funds, generating returns through capital appreciation, dividends, and exits via trade sales or IPOs, a structure typical of listed alternative asset managers.
- Private equity exits accelerate boosting performance fees
- European rate cuts revive deal activity and valuations
- Real estate segment NAV pressured by elevated interest rates
| Net Income: -100.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -1.52 > 1.0 |
| NWC/Revenue: -84.65% < 20% (prev -1.17k%; Δ 1.09k% < -1%) |
| CFO/TA -0.01 > 3% & CFO -53.5m > Net Income -100.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (63.9m) vs 12m ago -12.44% < -2% |
| Gross Margin: 53.29% > 18% (prev 1.37%; Δ 51.91% > 0.5%) |
| Asset Turnover: 8.64% > 50% (prev 1.20%; Δ 7.44% > 0%) |
| Interest Coverage Ratio: -1.35 > 6 (EBIT TTM -95.0m / Interest Expense TTM 70.5m) |
| A: -0.08 (Total Current Assets 336.6m - Total Current Liabilities 964.2m) / Total Assets 8.23b |
| B: 0.71 (Retained Earnings 5.89b / Total Assets 8.23b) |
| C: -0.01 (EBIT TTM -95.0m / Avg Total Assets 8.58b) |
| D: 3.04 (Book Value of Equity 6.01b / Total Liabilities 1.97b) |
| Altman-Z'' = 4.95 = AAA |
| DSRI: 0.15 (Receivables 246.1m/243.5m, Revenue 741.5m/107.1m) |
| GMI: 0.03 (GM 1.37% / 53.29%) |
| AQI: 1.01 (AQ_t 0.95 / AQ_t-1 0.94) |
| SGI: 6.92 (Revenue 741.5m / 107.1m) |
| TATA: -0.01 (NI -100.8m - CFO -53.5m) / TA 8.23b) |
| Beneish M = -0.36 (Cap -4..+1) = D |
As of August 23, 2026, the stock is trading at EUR 49.84 with a total of 58,965 shares traded. Over the past week, the price has changed by -3.69%, over one month by +14.05%, over three months by +10.41% and over the past year by -5.95%.
Current recommended Stop Loss: 47.00 (which is 5.7% or 2.1 ATR below the current price).
Eurazeo has no consensus analysts rating.
P/E Forward = 15.4321
P/S = 9.3882
P/B = 0.5607
P/EG = 0.0293
Revenue TTM = 741.5m EUR
EBIT TTM = -95.0m EUR
EBITDA TTM = -70.2m EUR
Long Term Debt = 199.3m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 975.0m EUR (from shortTermDebt, last quarter)
Debt = 1.73b EUR (from shortLongTermDebtTotal, last quarter) + Leases 79.6m
Net Debt = 1.64b EUR (calculated: Debt 1.73b - CCE 85.9m)
Enterprise Value = 4.94b EUR (3.29b + Debt 1.73b - CCE 85.9m)
Interest Coverage Ratio = -1.35 (Ebit TTM -95.0m / Interest Expense TTM 70.5m)
EV/FCF = -87.76x (Enterprise Value 4.94b / FCF TTM -56.2m)
FCF Yield = -1.14% (FCF TTM -56.2m / Enterprise Value 4.94b)
FCF Margin = -7.59% (FCF TTM -56.2m / Revenue TTM 741.5m)
Net Margin = -13.60% (Net Income TTM -100.8m / Revenue TTM 741.5m)
Gross Margin = 53.29% ((Revenue TTM 741.5m - Cost of Revenue TTM 346.4m) / Revenue TTM)
Gross Margin QoQ = -14.22% (prev 82.70%)
Tobins Q-Ratio = 0.60 (Enterprise Value 4.94b / Total Assets 8.23b)
Interest Expense / Debt = 4.08% (Interest Expense 70.5m / Debt 1.73b)
Taxrate = 25.0% (non-US conservative default 25%)
NOPAT = -71.3m (EBIT -95.0m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 0.35 (Total Current Assets 336.6m / Total Current Liabilities 964.2m)
Debt / Equity = 0.29 (Debt 1.73b / totalStockholderEquity, last quarter 6.01b)
Debt / EBITDA = -23.39 (negative EBITDA) (Net Debt 1.64b / EBITDA -70.2m)
Debt / FCF = -29.20 (negative FCF - burning cash) (Net Debt 1.64b / FCF TTM -56.2m)
Total Stockholder Equity = 6.54b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.17% (Net Income -100.8m / Total Assets 8.23b)
RoE = -1.54% (Net Income TTM -100.8m / Total Stockholder Equity 6.54b)
RoCE = -1.41% (EBIT -95.0m / Capital Employed (Equity 6.54b + L.T.Debt 199.3m))
RoIC = -0.87% (negative operating profit) (NOPAT -71.3m / Invested Capital 8.21b)
WACC = 7.47% (E(3.29b)/V(5.02b) * Re(9.79%) + D(1.73b)/V(5.02b) * Rd(4.08%) * (1-Tc(0.25)))
Discount Rate = 9.79% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -71.83 | Cagr: -7.81%
[DCF] Fair Price = unknown (Cash Flow -56.2m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: -31.55 | Revenue CAGR: -29.22% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=2.57 | Chg30d=-2.51% | Revisions=-40% | GrowthEPS=+146.3% | GrowthRev=-4.3%
EPS next Year (2027-12-31): EPS=8.62 | Chg30d=-1.26% | Revisions=+0% | GrowthEPS=+235.5% | GrowthRev=+23.3%
[Analyst] Revisions Ratio: -29% (up=1, down=3)